Yana G Najjar

16PUBLICATIONS
114CO-AUTHORS
Molecular targetsGene and molecular therapyMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 02, 2026
Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy.

|Jun 25, 2026
Updates on intratumoral therapies in melanoma.

|Jun 22, 2026
Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.

|Mar 07, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

Tricia R Cottrell, Michael T Lotze, Alaa Ali

|Feb 12, 2025
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.

Alexandra G Tompkins, Zane N Gray, Rebekah E Dadey

|Jan 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review.

Alessandra Cesano, Ryan Augustin, Luigi Barrea

Pageof 3

Frequent Collaborators

5 joint publications

Diwakar Davar

3 joint publications

John M Kirkwood

2 joint publications

Kalil G Abdullah

2 joint publications

Jeffrey I Traylor